Deura9™
(d9-Caffeine) Patents
Deura9™ is a registered trademark of Lennham Pharmaceuticals, Inc. under exclusive license to d9 Designs Inc. This product is covered by multiple issued and pending patents.
Patents
Patent Protection till 2039
Exclusive Global Rights to issued U.S. patents & pending international applications for all uses of deuterated caffeine in key markets.
01
U.S. Patent No. 10,582,716
02
U.S. Patent No. 10,765,130
03
U.S. Patent No. 11,547,127
04